Table 1 Prevalence of ESBL production in E. coli isolates from 13 target country studies
Country | ESBL-producing E. coli prevalence | Sample number/type | Reference |
|---|---|---|---|
Bangladesh | 67.5%, 68.0%, and 92.5% | 200 adults (feces), 200 poultry (ceca/feces), 120 wastewater | [8] |
Burkina Faso | 67.5% | 202 E. coli isolates (clinical) | [9] |
Cameroon | 34.4% | 90 E. coli isolated from blood culture of children (clinical) | [10] |
Côte d'Ivoire | 27%, 32%, 0% | 77 people, 38 dogs, 75 wildlife | [11] |
Democratic Republic of the Congo (DRC) | 98.2% | 57 multidrug-resistant E. coli isolates (clinical) | [12] |
Ethiopia | 17.4% | 224 E. coli isolates (clinical) | [13] |
Kenya | 44% | 406 children (clinical) | [14] |
Mali | 22% | 136 E. coli isolates (clinical) | [15] |
Mozambique | 32.6% | 230 clinical | [16] |
Nigeria | 32.2% | 115 E. coli isolates (poultry workers, chickens, farm/market environments) | [17] |
Senegal | 36.7% | 49 slaughterhouse effluent | [18] |
Tanzania | 21.7% | 350 children (rectal) (clinical) | [19] |
Uganda | 50% | 42 multidrug-resistant E. coli isolates from stool (30 people, 12 cattle) | [20] |